Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Maleki

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Science Translational Medicine|February 25, 2021
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitisXiaojun Jiang, Annika Bergquist, Britt-Sabina Löscher, et al.
BMC Infectious Diseases|May 28, 2021
Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responsesHedvig Glans, Sara Gredmark-Russ, Mikaela Olausson, et al.
Plos Pathogens|June 23, 2017
Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airwaysSaskia Scholz, Faezzah Baharom, Gregory Rankin, et al.
Scientific Reports|April 8, 2021
Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titersNina Lagerqvist, Kimia T Maleki, Jenny Verner-Carlsson, et al.
Cell Reports|August 22, 2019
Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5Carles Solà-Riera, Shawon Gupta, Kimia T Maleki, et al.
Clinical & Translational Immunology|December 21, 2020
Innate lymphoid cell composition associates with COVID-19 disease severityMarina García, Efthymia Kokkinou, Anna Carrasco García, et al.
Clinical & Translational Immunology|July 19, 2021
Generation of plasma cells and CD27<sup>-</sup>IgD<sup>-</sup> B cells during hantavirus infection is associated with distinct pathological findingsPriscilla F Kerkman, Andy Dernstedt, Lalitha Tadala, et al.
Science Immunology|September 29, 2020
MAIT cell activation and dynamics associated with COVID-19 disease severityTiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, et al.
Clinical & Translational Immunology|July 14, 2021
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional AnomaliesTobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Science Translational Medicine|February 25, 2021
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitisXiaojun Jiang, Annika Bergquist, Britt-Sabina Löscher, et al.
BMC Infectious Diseases|May 28, 2021
Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responsesHedvig Glans, Sara Gredmark-Russ, Mikaela Olausson, et al.
Plos Pathogens|June 23, 2017
Human hantavirus infection elicits pronounced redistribution of mononuclear phagocytes in peripheral blood and airwaysSaskia Scholz, Faezzah Baharom, Gregory Rankin, et al.
Scientific Reports|April 8, 2021
Evaluation of 11 SARS-CoV-2 antibody tests by using samples from patients with defined IgG antibody titersNina Lagerqvist, Kimia T Maleki, Jenny Verner-Carlsson, et al.
Cell Reports|August 22, 2019
Hantavirus Inhibits TRAIL-Mediated Killing of Infected Cells by Downregulating Death Receptor 5Carles Solà-Riera, Shawon Gupta, Kimia T Maleki, et al.
Clinical & Translational Immunology|December 21, 2020
Innate lymphoid cell composition associates with COVID-19 disease severityMarina García, Efthymia Kokkinou, Anna Carrasco García, et al.
Clinical & Translational Immunology|July 19, 2021
Generation of plasma cells and CD27<sup>-</sup>IgD<sup>-</sup> B cells during hantavirus infection is associated with distinct pathological findingsPriscilla F Kerkman, Andy Dernstedt, Lalitha Tadala, et al.
Science Immunology|September 29, 2020
MAIT cell activation and dynamics associated with COVID-19 disease severityTiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, et al.
Clinical & Translational Immunology|July 14, 2021
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisationJohn Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2023
Dynamic MAIT Cell Recovery after Severe COVID-19 Is Transient with Signs of Heterogeneous Functional AnomaliesTobias Kammann, Jean-Baptiste Gorin, Tiphaine Parrot, et al.
Pageof 3